These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3345297)
1. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). I. Characterization and preliminary evaluation in plasma. Gaffney PJ; Creighton LJ; Perry MJ; Callus M; Thorpe R; Spitz M Br J Haematol; 1988 Jan; 68(1):83-90. PubMed ID: 3345297 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions. Gaffney PJ; Creighton LJ; Callus M; Thorpe R Br J Haematol; 1988 Jan; 68(1):91-6. PubMed ID: 3345298 [TBL] [Abstract][Full Text] [Related]
3. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264 [TBL] [Abstract][Full Text] [Related]
4. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies. Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis]. Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330 [TBL] [Abstract][Full Text] [Related]
6. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164 [TBL] [Abstract][Full Text] [Related]
7. An immunoassay for human D dimer using monoclonal antibodies. Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576 [TBL] [Abstract][Full Text] [Related]
8. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Greenberg CS; Devine DV; McCrae KM Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576 [TBL] [Abstract][Full Text] [Related]
9. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA; Dempfle CE; Matsuda M; Heene DL Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [TBL] [Abstract][Full Text] [Related]
10. The importance of antibody specificity in measuring cross-linked fibrin degradation products by ELISA. Eisenberg PR; Rylatt DB; Rusticali F; Ferrini D; Ottani F; Galvani M Blood Coagul Fibrinolysis; 1997 Mar; 8(2):105-13. PubMed ID: 9518041 [TBL] [Abstract][Full Text] [Related]
11. Unreliability of current serum fibrin degradation product (FDP) assays. Gaffney PJ; Perry MJ Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388 [TBL] [Abstract][Full Text] [Related]
12. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Lane DA; Preston FE; VanRoss ME; Kakkar VV Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218 [TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813 [TBL] [Abstract][Full Text] [Related]
14. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies. Raut S; Gaffney PJ Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252 [TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation. Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia. Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830 [TBL] [Abstract][Full Text] [Related]
19. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia]. Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040 [TBL] [Abstract][Full Text] [Related]